{"data":[{"accessionNo":"0002012383-26-003867","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3287021,"percentOfClass":5,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-26-097825","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"InnoCare Pharma Limited","reportingCik":null,"personType":"OO","sharesOwned":7000000,"percentOfClass":10.4,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-26-097825","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"InnoCare Pharma Inc.","reportingCik":null,"personType":"CO","sharesOwned":7000000,"percentOfClass":10.4,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-26-097825","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-26","reportingPerson":"Ocean Prominent Limited","reportingCik":null,"personType":"OO","sharesOwned":7000000,"percentOfClass":10.4,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000902219-26-000315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas Biopharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":6566134,"percentOfClass":10.1,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000902219-26-000315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas Biopharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":6566134,"percentOfClass":10.1,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000902219-26-000315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas Biopharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":6566134,"percentOfClass":10.1,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000902219-26-000315","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas Biopharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":6566134,"percentOfClass":9.9,"filedAt":"2026-09-08","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001953107-26-000015","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-19","reportingPerson":"Enavate Sciences GP, LLC","reportingCik":"0001953107","personType":"OO","sharesOwned":3245404,"percentOfClass":4.9,"filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001953107-26-000015","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-19","reportingPerson":"Zebra Aggregator, LP","reportingCik":"0002037042","personType":"PN","sharesOwned":3245404,"percentOfClass":4.9,"filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Simeon George","reportingCik":"0001595117","personType":"IN","sharesOwned":5037854,"percentOfClass":7.7,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital Management, LLC","reportingCik":"0001853723","personType":"OO","sharesOwned":5037854,"percentOfClass":7.7,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital Partners II, LP","reportingCik":"0001966609","personType":"PN","sharesOwned":1946564,"percentOfClass":3,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital Fund II Aggregator, LP","reportingCik":"0001966610","personType":"PN","sharesOwned":1946564,"percentOfClass":3,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"AMZL, LP","reportingCik":"0001971694","personType":"PN","sharesOwned":1917895,"percentOfClass":2.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital SMA Partners, LP","reportingCik":"0002039882","personType":"PN","sharesOwned":1917895,"percentOfClass":2.9,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital Opportunities Partners I, LP","reportingCik":null,"personType":"PN","sharesOwned":1173395,"percentOfClass":1.8,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001072613-26-000694","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"SR One Capital Opportunities Fund I, LP","reportingCik":"0001955314","personType":"PN","sharesOwned":1173395,"percentOfClass":1.8,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-055643","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-04-29","reportingPerson":"MOULDER LEON O JR","reportingCik":"0001228865","personType":"IN","sharesOwned":3220880,"percentOfClass":5.09,"filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-055643","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-04-29","reportingPerson":"Tellus BioVentures, LLC","reportingCik":null,"personType":"OO","sharesOwned":1786039,"percentOfClass":2.9,"filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-055643","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-04-29","reportingPerson":"Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008","reportingCik":null,"personType":"OO","sharesOwned":36928,"percentOfClass":0.1,"filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-039279","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Leon O. Moulder, Jr.","reportingCik":"0001228865","personType":"IN","sharesOwned":3029921,"percentOfClass":4.794,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-039279","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Tellus BioVentures, LLC","reportingCik":null,"personType":"OO","sharesOwned":1726039,"percentOfClass":2.77,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-039279","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":"98937L105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008","reportingCik":null,"personType":"OO","sharesOwned":36928,"percentOfClass":0.06,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000315066-26-000571","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA INC","ticker":"ZBIO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":7652255,"percentOfClass":14.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0000315066-26-000571","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA INC","ticker":"ZBIO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":7652255,"percentOfClass":14.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-003758","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-07","reportingPerson":"Leon O. Moulder, Jr.","reportingCik":"0001228865","personType":"IN","sharesOwned":2806792,"percentOfClass":5.159,"filedAt":"2026-01-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-003758","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-07","reportingPerson":"Tellus BioVentures, LLC","reportingCik":null,"personType":"OO","sharesOwned":1672039,"percentOfClass":3.1,"filedAt":"2026-01-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-26-003758","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-07","reportingPerson":"Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008","reportingCik":null,"personType":"OO","sharesOwned":36928,"percentOfClass":0.1,"filedAt":"2026-01-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001388325-25-000027","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Novo Holdings A/S","reportingCik":null,"personType":"CO","sharesOwned":2000000,"percentOfClass":4.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-25-098959","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-07","reportingPerson":"InnoCare Pharma Inc.","reportingCik":null,"personType":"CO","sharesOwned":5000000,"percentOfClass":9.4,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-25-098959","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-07","reportingPerson":"Ocean Prominent Limited","reportingCik":null,"personType":"OO","sharesOwned":5000000,"percentOfClass":9.4,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001213900-25-098959","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-07","reportingPerson":"InnoCare Pharma Limited","reportingCik":null,"personType":"OO","sharesOwned":5000000,"percentOfClass":9.4,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"Simeon George","reportingCik":null,"personType":"IN","sharesOwned":5037854,"percentOfClass":9.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital Management, LLC","reportingCik":"0001853723","personType":"OO","sharesOwned":5037854,"percentOfClass":9.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001953107-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-09","reportingPerson":"Zebra Aggregator, LP","reportingCik":"0002037042","personType":"PN","sharesOwned":3919159,"percentOfClass":7.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001953107-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-09","reportingPerson":"Enavate Sciences GP, LLC","reportingCik":"0001953107","personType":"OO","sharesOwned":3919159,"percentOfClass":7.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Patrick G. Enright","reportingCik":"0001253886","personType":"IN","sharesOwned":2631522,"percentOfClass":4.9,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Juliet Tammenoms Bakker","reportingCik":"0001431159","personType":"IN","sharesOwned":2607199,"percentOfClass":4.9,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital Fund II Aggregator, LP","reportingCik":null,"personType":"PN","sharesOwned":1946564,"percentOfClass":3.6,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital Partners II, LP","reportingCik":null,"personType":"PN","sharesOwned":1946564,"percentOfClass":3.6,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"AMZL, LP","reportingCik":null,"personType":"PN","sharesOwned":1917895,"percentOfClass":3.6,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital SMA Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":1917895,"percentOfClass":3.6,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Longitude Capital Partners IV, LLC","reportingCik":"0001829169","personType":"OO","sharesOwned":1832669,"percentOfClass":3.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Longitude Venture Partners IV, L.P.","reportingCik":"0001787456","personType":"PN","sharesOwned":1832669,"percentOfClass":3.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital Opportunities Partners I, LP","reportingCik":null,"personType":"PN","sharesOwned":1173395,"percentOfClass":2.2,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-239173","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-10-09","reportingPerson":"SR One Capital Opportunities Fund I, LP","reportingCik":null,"personType":"PN","sharesOwned":1173395,"percentOfClass":2.2,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Longitude Prime Fund, L.P.","reportingCik":"0001865844","personType":"PN","sharesOwned":774530,"percentOfClass":1.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001193125-25-238370","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"ZENAS BIOPHARMA, INC.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-09","reportingPerson":"Longitude Prime Partners, LLC","reportingCik":"0001865779","personType":"OO","sharesOwned":774530,"percentOfClass":1.4,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-25-098408","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-07","reportingPerson":"Leon O. Moulder, Jr.","reportingCik":"0001228865","personType":"IN","sharesOwned":2594662,"percentOfClass":4.8,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-25-098408","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-07","reportingPerson":"Tellus BioVentures, LLC","reportingCik":null,"personType":"OO","sharesOwned":1672039,"percentOfClass":3.1,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"},{"accessionNo":"0001104659-25-098408","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001953926","issuerName":"Zenas BioPharma, Inc.","ticker":"ZBIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-07","reportingPerson":"Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008","reportingCik":null,"personType":"OO","sharesOwned":36928,"percentOfClass":0.1,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/zbio"}],"updatedAt":"2026-11-05T10:10:27.110Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/zbio","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}